Kelly Hyman

Kelly Hyman

Searcy Denney Scarola Barnhart & Shipley

Contact  |  View Bio  |  RSS

Latest Publications

Share:

Searcy Denney Files Another Lawsuit Over Defective DePuy Pinnacle Hip Implant

In early May, Searcy Denney mass tort lawyers Cal Warriner and Brenda Fulmer filed yet another lawsuit against Johnson & Johnson and DePuy Orthopaedics, Inc. This latest case was filed on behalf of a Southwest Florida...more

5/12/2015 - DePuy Hip Replacement Johnson & Johnson Multidistrict Litigation

Xarelto Cases Present Several Common Issues

In July 2011, the Federal Drug Administration (FDA) approved Xarelto, an oral anticoagulant prescribed for prevention of deep vein thrombosis, pulmonary embolism, and strokes in patients with atrial fibrillation. Based on...more

3/25/2015 - FDA Multidistrict Litigation Prescription Drugs Wrongful Death

California Woman’s Punitive Damages Claim Will Proceed Against Boston Scientific

California resident Roseanne Sanchez was implanted with the Pinnacle kit to treat pelvic organ prolapse and the Advantage System to treat stress urinary incontinence. After the surgery, Ms. Sanchez experienced several...more

2/4/2015 - Medical Devices Medtronic v Boston Scientific Multidistrict Litigation Punitive Damages Transvaginal Mesh

Lawsuits Piling up Against Makers of Risperdal, Invega

Antipsychotic Drugs Have Caused Breast Growth in Men - More than two years after Johnson & Johnson settled a lawsuit with a 21-year-old man who experienced an adverse side effect from Risperdal, hundreds of other young...more

1/21/2015 - Johnson & Johnson Medical Research Pharmaceutical Pharmaceutical Manufacturers Prescription Drugs

JPML Asked to Consolidate Benicar Lawsuits

Daiichi Sankyo, Inc. developed the prescription medication Benicar (Olmesartan Medoxomil) to treat high blood pressure. In April 2002, the U.S. Food and Drug Administration (FDA) approved Benicar. Since that time, it has...more

12/30/2014 - FDA Multidistrict Litigation Pharmaceutical Pharmaceutical Manufacturers

Xarelto Suits Sent to Louisiana

Xarelto (rivaroxaban) is a new generation anticoagulant in a class of drugs known as direct thrombin inhibitors. It is a blood thinner used to reduce the risk of blood clots and strokes. Xarelto has also been marketed as...more

12/23/2014 - Bayer FDA Johnson & Johnson Multidistrict Litigation Pharmaceutical Pharmaceutical Manufacturers

Brand Name Drug Maker Can be Liable for Injuries from a Generic Version

The Alabama Supreme Court in Wyeth v. Weeks has reaffirmed its ruling in a case questioning whether a brand-name drug maker can be held liable for injuries from a generic version. Plaintiffs Danny and Vicki Weeks sued...more

8/26/2014 - Generic Drugs Liability Pharmaceutical Pharmaceutical Manufacturers Prescription Drugs

Keeping Our Kids Healthy: Pediatric Medicine Development

Children are a precious commodity and it is important that they are cared for appropriately. Children deserve the best care so they can grow and live happy and fulfilled lives. Pediatric products development is in high demand...more

7/21/2014 - Children's Products Healthcare Medical Research Pharmaceutical

FDA Warns Against Power Morcellation

Most women will develop uterine fibroids at some point in their lives. Fibroids are common, and affect half or more women during their reproductive years. Most women with fibroids are unaware they have them, but other women...more

7/11/2014 - FDA Healthcare Transvaginal Ultrasounds

Scotland Leads the Globe in Halting Transvaginal Mesh Implants

It started with one area in Scotland. This month, one of the 14 health boards in Scotland decided to ban the use of transvaginal mesh. Now the entire country has decided to do so....more

6/27/2014 - Transvaginal Mesh

Jury Awards $10.9 Million in Asbestos Case

A Fresco County Superior Court jury returned a multi-million dollar verdict in favor of the family of James Phillips on June 2, 2014. Mr. Phillips was an auto mechanic who was exposed to asbestos dust from automotive...more

6/20/2014 - Asbestos Litigation Jury Awards

FDA Imposes Firmer Rules on Tanning Salons

The Federal Drug Administration (“FDA”) is tightening rules on tanning salons because of the cancer risk posed by the use of sunlamps. Due to the increased risk of melanoma, future tanning bed designs will include warnings...more

6/16/2014 - Cancer FDA New Regulations Tanning Salons

Removal of Mesh Might Not Improve Side Effects

Vaginal mesh is a device that is implanted in woman to help support a woman’s pelvic organs. However, there are cases where the women suffer infections, bleeding, the mesh eroded, difficulty with sex and problems with...more

5/29/2014 - Transvaginal Mesh

J&J Takes Morcellator Off the Market Due to Cancer Threat

It is not exactly a recall – but Johnson and Johnson (J&J) has removed from the market its Laparoscopic Power Morcellation, a medical device used to break uterine fibroids into little pieces using a cylindrical blade with a...more

5/22/2014 - Cancer Johnson & Johnson Medical Devices

J&J Halts Sale of Fibroid Surgery Device After Fear of Spreading Cancer

It is a common treatment for uterine fibroids but now Johnson & Johnson (J&J) is halting the sale and promotion of its popular surgical device, known as a morcellator, because of fears it could spread a deadly cancer....more

5/7/2014

Dallas Woman Awarded $1.2 Million, Mesh Called Defectively Designed

For the first time, a Texas jury has decided the pelvic mesh made by healthcare giant Johnson & Johnson was defectively designed. The jury awarded the 64-year-old Dallas woman $1.2 million following a two-and-a half week...more

4/16/2014 - Design Defects Ethicon Jury Awards Medical Devices Transvaginal Mesh

Consumer Group Encourages AG Probe into J&J Document Destruction

The U.S. Attorney General’s office says it is reviewing an open letter submitted by a consumer group encouraging a criminal probe into the destruction by Johnson & Johnson (J&J) of pelvic mesh litigation documents....more

4/4/2014 - Attorney Generals Destruction of Evidence Johnson & Johnson Transvaginal Mesh

17 Results
|
View per page
Page: of 1

All the intelligence you need, in one easy email:

Great! Your first step to building an email digest of JD Supra authors and topics. Log in with LinkedIn so we can start sending your digest...

Sign up for your custom alerts now, using LinkedIn ›

* With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name.
×